JPRN-C000000174已完成3 期
A phase III trial comparing preoperative chemotherapy to chemoradiotherapy before surgery in patients with pathologically-confirmed stage IIIA-N2 non-small cell lung cancer. - Phase III trial of chemotherapy versus chemoradiotherapy before surgery in stage IIIA-N2 NSCLC
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active double cancer. The definition of inactive is that disease-free interval is more than 5 years. However, patients who have history of completely resected early gastric cancer,uterine cervical cancer, completely resected skin malignancies (except malignant melanoma)are acceptable. 2)Uncontrollable angina or myocardial infarction within the past 3 months. Severe heart disease, arrhythmia requiring treatment. 3)Uncontrollable hypertension and Diabetes Mellitus. 4)Patients with severe COPD (FEV1.0percent less than 65)or pulmonary fibrosis recognized with computed tomography scanning. 5)Weight loss more than 10 percent within the past 6 months 6)Women during pregnancy or lactating. 7)ther unsuitable patient judged by a physician.
研究者
相似试验
招募中
不适用
A phase 2 clinical trial of preoperative chemoradiation therapy for locally advanced low rectal cancer with limited radiation field to the lesser pelvisocally advanced low rectal cancerJPRN-UMIN000013383Gunma University Graduate School of Medicine52
已完成
不适用
A phase II study of preoperative chemotherapy cosisting docetaxel, oxaliplatin and S-1 for the clinical Stage III gastric cancerGastric cancerJPRN-UMIN000017652Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine50
尚未招募
不适用
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancerJPRN-UMIN000016518Meiwa Hospital60
已完成
1 期
Phase I/II randomised study on pre-operative chemotherapy in advanced ovarian cancerOvarian cancerMalignant neoplasm of ovaryCancerISRCTN19184035HS R&D Regional Programme Register - Department of Health (UK)60
已完成
不适用
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryPER-155-08EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG),